Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Findings from a study led by Colin Goding uncover an ancient mechanism that makes cancer cells invasive, explains melanoma’s resistance to therapy and opens the door to development of novel cancer therapies. Published in the current issue of the journal Genes & Development, the study illuminates the crucial role that punishing conditions within the tumour play in molding a subset of tumor cells into an invasive state.